发明名称 ARYLSULFONAMIDE-BASED MATRIX METALLOPROTEASE INHIBITORS.
摘要 <p>The present invention provides a compound of formula (I):said compound is inhibitor of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP-13, and thus can be employed for the treatment of a disorder or disease characterized by abnormal activity of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP- 13. Accordingly, the compound of formula (I) can be used in treatment of disorders or diseases mediated by MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12, and/or MMP- 13. Finally, the present invention also provides a pharmaceutical composition.</p>
申请公布号 MX2010010525(A) 申请公布日期 2010.10.25
申请号 MX20100010525 申请日期 2009.03.23
申请人 NOVARTIS AG. 发明人 CLAUS EHRHARDT;MICHAEL SHULTZ;RUBEN ALBERTO TOMMASI;PASCAL RIGOLLIER;OLIVIER ROGEL;LESLIE WIGHTON MCQUIRE
分类号 C07C311/16;A61K31/18;A61P29/00;C07C317/24;C07C323/24;C07D207/20;C07D209/08;C07D211/24;C07D213/40;C07D235/06;C07D295/116;C07D333/18 主分类号 C07C311/16
代理机构 代理人
主权项
地址